Abeona therapeutics announces participation at the jefferies london healthcare conference

New york and cleveland, nov. 16, 2021 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a fully-integrated leader in gene and cell therapy, today announced that vish seshadri, ph.d., chief executive officer of abeona, will participate virtually in a fireside chat at the jefferies london healthcare conference being held november 16-19, 2021.
ABEO Ratings Summary
ABEO Quant Ranking